OASM

Oasmia Pharmaceuticals AB (OASM)

Oasmia Pharmaceuticals AB

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:OASM

1 2 3 4 5 6 7 8 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
07/03/2022	14h35	Business Wire	CORRECTING and REPLACING Whiting and Oasis to Combine in $6.0 Billion Merger of Equals Transaction	NASDAQ:OASM	Oasmia Pharmaceuticals AB
07/03/2022	13h20	Business Wire	Whiting and Oasis to Combine in $6.0 Billion Merger of Equals Transaction	NASDAQ:OASM	Oasmia Pharmaceuticals AB
27/11/2019	15h54	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
21/11/2019	15h41	Edgar (US Regulatory)	Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
23/08/2019	16h25	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
23/08/2019	14h01	Edgar (US Regulatory)	Notice of Termination of a Foreign Private Issuer's Registration of a Class of Securities Under Section 12(b) (15f-12b)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
21/08/2019	22h06	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
15/08/2019	22h06	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
13/08/2019	12h03	Edgar (US Regulatory)	Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeeme...	NASDAQ:OASM	Oasmia Pharmaceuticals AB
13/08/2019	12h00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
08/08/2019	22h15	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
06/08/2019	22h31	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
01/08/2019	22h08	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
09/07/2019	22h06	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
09/07/2019	22h06	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
02/07/2019	22h08	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
28/06/2019	22h06	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
26/06/2019	22h08	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
25/06/2019	22h06	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
20/05/2019	17h36	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
12/04/2019	22h40	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
04/04/2019	22h07	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
01/04/2019	22h10	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
01/04/2019	22h09	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
27/03/2019	21h08	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
25/03/2019	21h33	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
20/03/2019	11h04	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
06/03/2019	22h07	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
04/03/2019	22h06	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:OASM	Oasmia Pharmaceuticals AB
01/03/2019	22h09	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:OASM	Oasmia Pharmaceuticals AB